AIM Vaccine Co., Ltd. (HKG: 6660)
Hong Kong
· Delayed Price · Currency is HKD 5.89
+0.04 (0.68%)
Jan 6, 2025, 4:08 PM HKT
AIM Vaccine Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -1,190 | -1,301 | -319.6 | -692.77 | 379.29 | 117.41 |
| Depreciation & Amortization | 170.63 | 169.18 | 163.41 | 142.24 | 128.34 | 109.44 |
| Other Amortization | 5.52 | 5.52 | 3.03 | 2.06 | - | - |
| Loss (Gain) From Sale of Assets | 7.12 | 7.15 | 0.69 | 0.21 | 2.01 | 5.01 |
| Asset Writedown & Restructuring Costs | 1,785 | 1,785 | - | - | 3.56 | - |
| Loss (Gain) From Sale of Investments | - | - | -3.07 | -1.67 | -1.31 | - |
| Stock-Based Compensation | 7.65 | -14.2 | 225.76 | 952.13 | 23.48 | 7.78 |
| Provision & Write-off of Bad Debts | 4.36 | 4.18 | 27.22 | 7.98 | 0.18 | -2.22 |
| Other Operating Activities | -892.9 | -932.86 | -131.15 | 10.67 | 53.99 | -5.54 |
| Change in Accounts Receivable | -46.08 | 43.35 | -16.16 | -201.77 | -425.2 | 191.97 |
| Change in Inventory | 51.06 | -15.64 | -161.99 | -136.36 | -30.49 | -56.41 |
| Change in Accounts Payable | 0.87 | -13.23 | 21.82 | 13.79 | -4.95 | 26.42 |
| Change in Unearned Revenue | -1.09 | -0.26 | 16.12 | -28.91 | -16.18 | -18.84 |
| Change in Other Net Operating Assets | 84.32 | 97.56 | 63.6 | 25.82 | 137.63 | -48 |
| Operating Cash Flow | -13.66 | -165.5 | -110.32 | 93.4 | 250.33 | 327.01 |
| Operating Cash Flow Growth | - | - | - | -62.69% | -23.45% | - |
| Capital Expenditures | -128.58 | -158.92 | -779.01 | -1,125 | -666.68 | -314.78 |
| Sale of Property, Plant & Equipment | 1.73 | 1.66 | 0.19 | 0.02 | 2.7 | 7.41 |
| Cash Acquisitions | - | - | - | -250.38 | - | - |
| Sale (Purchase) of Intangibles | -133.6 | -80.14 | -77.33 | -0.23 | 0.01 | -0.48 |
| Investment in Securities | 37 | 8.12 | -56.93 | 5.9 | 51.31 | -50 |
| Other Investing Activities | -60.49 | -42.69 | 54.93 | 32.55 | 7.75 | 17.65 |
| Investing Cash Flow | -283.95 | -271.96 | -858.15 | -1,338 | -604.92 | -340.2 |
| Long-Term Debt Issued | - | 1,458 | 1,282 | 537.83 | 270.5 | 293.6 |
| Long-Term Debt Repaid | - | -1,048 | -452.86 | -261.04 | -395.71 | -185.02 |
| Net Debt Issued (Repaid) | 286.76 | 410.27 | 829.16 | 276.79 | -125.21 | 108.58 |
| Issuance of Common Stock | - | - | 162.02 | 553.48 | 1,894 | 268 |
| Other Financing Activities | -54.14 | -48.2 | -10.8 | -42.24 | -630.23 | -507.03 |
| Financing Cash Flow | 232.63 | 362.07 | 980.37 | 788.02 | 1,139 | -130.45 |
| Foreign Exchange Rate Adjustments | 0.43 | 2.27 | -2.38 | - | - | - |
| Net Cash Flow | -64.55 | -73.12 | 9.53 | -456.09 | 784.19 | -143.63 |
| Free Cash Flow | -142.23 | -324.42 | -889.33 | -1,032 | -416.35 | 12.23 |
| Free Cash Flow Margin | -12.01% | -27.32% | -70.35% | -65.73% | -25.42% | 1.29% |
| Free Cash Flow Per Share | -0.12 | -0.27 | -0.74 | -0.89 | -0.43 | 0.01 |
| Cash Interest Paid | 54.14 | 43.2 | 24.59 | 10.3 | 15.63 | 10.92 |
| Cash Income Tax Paid | 6.39 | 0.92 | 59.57 | 90.03 | 55.33 | 57.48 |
| Levered Free Cash Flow | -1,110 | -1,217 | -801.43 | -514.34 | -468.21 | - |
| Unlevered Free Cash Flow | -1,076 | -1,189 | -785.37 | -507.65 | -458.37 | - |
| Change in Net Working Capital | -147.62 | -139.17 | 43.86 | 73.01 | 233.23 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.